Delivery Order SPE2DB20D1100-SPE2DB25FE0UZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,957.52 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) valued at $1,592.16. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and was competitively awarded....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $1,686.07. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Adderall XR 10 mg capsules in quantities of 100 units, with a contract ceiling value of $1,194.12. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 16, 2025. The award supports federal medical procurement needs, with performance of work occurring...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) under a firm fixed-price contract valued at $1,194.12. This is a non-set-aside award executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The delivery order has...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,146.35 for Adderall XR 20 mg capsules (100 count) on June 2, 2025, with completion scheduled for June 3, 2025. This contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's significantly larger...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) valued at $3,066.16, with completion scheduled for September 16, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running...
- The Defense Logistics Agency awarded a $2,308.08 delivery order contract to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Adderall XR 10 mg capsules (100-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 18, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract value of $1,057.62. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's broader pharmaceutical supply arrangement with the agency. The place of performance is the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $3,890.69 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0UZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract value of $6,109.22. This non-set-aside, competitively awarded delivery order is classified as firm fixed price and is scheduled for completion by September 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is fulfilling this requirement under its broader relationship with the DLA's medical supply chain, which supports critical pharmaceutical needs for military and veteran healthcare systems. This delivery order represents a routine transaction within AmerisourceBergen Drug Corp's extensive federal contract portfolio with the Defense Logistics Agency. The award is a child contract under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 9/23/25 |